Emtricitabine/Tenofovir disoproxil Stada

This medication treats HIV-1 infection in adults and adolescents and can also help reduce the risk of getting HIV-1.

Form
tabletti, kalvopäällysteinen
Strength
200 mg / 245 mg
Active Ingredient
Tenofovir disoproxil succinate
Manufacturer
STADA Arzneimittel AG

How to Use

Dosage

For adults and adolescents (12-18 years old, weighing at least 35 kg), take one tablet daily.

Method

Take with food whenever possible. If you have trouble swallowing, crush the tablet with a spoon and mix with about 100 ml (half a glass) of water, orange juice, or grape juice, then drink immediately.

Important

Do not exceed one tablet per day unless directed by your doctor.

Possible Side Effects

COMMON
  • Diarrhea
  • Vomiting
  • Nausea
  • Dizziness
  • Headache
  • Rash
  • Feeling weak
  • Stomach pain
  • Trouble sleeping
  • Abnormal dreams
  • Digestion problems (e.g., feeling unwell after meals, bloating, gas)
  • Rashes (e.g., red spots/patches, sometimes with blisters and skin swelling), itching, skin discoloration (e.g., dark patches)
  • Other allergic reactions (e.g., wheezing, swelling, lightheadedness)
  • Bone loss
  • Low blood phosphate levels
  • High creatine kinase levels
  • Low white blood cell count (may increase infection risk)
  • High triglyceride (fatty acids) levels
  • High bile acid or sugar levels in blood
  • Liver or pancreas problems
RARE
  • Abdominal pain from pancreatitis
  • Swelling of face, lips, tongue, or throat
  • Anemia (low red blood cell count)
  • Muscle breakdown, muscle pain or weakness (due to kidney tubule damage)
  • Lactic acidosis (too much lactic acid in the blood)
  • Fatty liver
  • Yellow skin or eyes, itching, stomach pain from liver inflammation
  • Kidney inflammation, frequent urination and thirst, kidney failure, kidney tubule damage
  • Softening of bones (with bone pain, sometimes leading to fractures)
  • Back pain due to kidney problems
  • Low blood potassium levels
  • High blood creatinine levels
  • Changes in urine

Important Warnings

  • Do not take this medicine if you are allergic to emtricitabine, tenofovir, or any other ingredient. Tell your doctor right away if this applies to you.
  • If you are taking this medicine to reduce HIV risk, you must be HIV-negative before starting. Get tested to confirm you don't have HIV.
  • If you get flu-like symptoms (tiredness, fever, muscle aches, headache, rash, night sweats, swollen glands, vomiting, or diarrhea), tell your doctor, as these could be signs of a recent HIV infection.
  • To reduce HIV risk, take this medicine every day and practice safe sex by using condoms. Do not share personal items that may have blood or body fluids, and get tested for other STIs.
  • This medicine can affect your kidneys. Your doctor will do blood tests to check kidney function before and during treatment. Tell your doctor if you have kidney problems or have had them in the past.
Show 7 more warnings
  • Talk to your doctor if you have osteoporosis, bone fractures, or other bone problems, as this medicine may affect your bone health.
  • Tell your doctor if you have liver disease, especially Hepatitis B. It is very important not to stop taking this medicine without talking to your doctor, as stopping could worsen Hepatitis B.
  • This medicine may cause dizziness. If you feel dizzy, do not drive or use any tools or machines.
  • Do not stop taking this medicine without talking to your doctor first. Stopping treatment for HIV can make it less effective, and stopping for prevention can increase your risk of getting HIV.
  • Lactic acidosis (too much lactic acid in the blood) is a rare but life-threatening side effect. Seek immediate medical attention if you suspect you have it (symptoms include deep, fast breathing, drowsiness, nausea, vomiting, stomach pain).
  • After starting HIV treatment, your immune system may get stronger and react to old infections, causing inflammation. Autoimmune diseases can also occur. Watch for new symptoms like muscle weakness, joint pain, or tremors, and tell your doctor immediately.
  • Some patients on long-term HIV treatment may develop osteonecrosis (bone tissue death due to lack of blood supply). Symptoms include stiff joints, joint pain, and difficulty moving. Report these to your doctor.